EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock closed at $22.76 on 1/12/24 after a major increase of 11.8%. However, this advance was accompanied by below average trading volume at 81% of normal. The stock has been exceptionally strong relative to the market over the last nine months and has risen 14.2% during the last week.
Current PriceTarget Research Rating
EYPT’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to be Value Creation neutral.
EyePoint Pharmaceuticals has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. EyePoint Pharmaceuticals has a very low Appreciation Score of 3 but a very high Power Rating of 97, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment